Pfizer's GLP-1 drug showed 12% weight loss over six months with just one monthly injection. Experts say it could be years before it receives regulatory approval ...
Pfizer has reported promising mid-stage trial results for berobenatide, an experimental weight-loss and diabetes medication that could become the world's first once-a-month GLP-1 injection if approved ...
Hosted on MSN
Pfizer’s new weight-loss shot: Can one injection a month change obesity treatment as we know it?
Pharmaceutical giant Pfizer has unveiled encouraging mid-stage trial results for berobenatide, an experimental anti-obesity and diabetes drug designed to be taken just once a month. If approved, it ...
Add Yahoo as a preferred source to see more of our stories on Google. Pfizer's GLP-1 drug showed 12% weight loss over six months with just one monthly injection. Experts say it could be years before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results